NVAX's selloff today may stem from the unwillingness of Congress (so far) to commit more funding for COVID vaccines and therapeutics. (This was a pretty big topic on MRNA's webcast yesterday.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”